Tomoyuki Asano

1.7k total citations
113 papers, 924 citations indexed

About

Tomoyuki Asano is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Tomoyuki Asano has authored 113 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Rheumatology, 45 papers in Immunology and 40 papers in Molecular Biology. Recurrent topics in Tomoyuki Asano's work include Inflammasome and immune disorders (28 papers), Systemic Lupus Erythematosus Research (27 papers) and Autoimmune and Inflammatory Disorders Research (16 papers). Tomoyuki Asano is often cited by papers focused on Inflammasome and immune disorders (28 papers), Systemic Lupus Erythematosus Research (27 papers) and Autoimmune and Inflammatory Disorders Research (16 papers). Tomoyuki Asano collaborates with scholars based in Japan, United States and Tanzania. Tomoyuki Asano's co-authors include Shuzo Sato, Hiroshi Watanabe, Kiyoshi Migita, Hiroko Kobayashi, Yuya Fujita, Naoki Matsuoka, Eiji Suzuki, Jumpei Temmoku, Haruki Matsumoto and Hiromasa Ohira and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Medicine.

In The Last Decade

Tomoyuki Asano

96 papers receiving 911 citations

Peers

Countries citing papers authored by Tomoyuki Asano

Since Specialization

Citations

This map shows the geographic impact of Tomoyuki Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Asano more than expected).

Fields of papers citing papers by Tomoyuki Asano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Asano. The network helps show where Tomoyuki Asano may publish in the future.

Co-authorship network of co-authors of Tomoyuki Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Asano. A scholar is included among the top collaborators of Tomoyuki Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Asano. Tomoyuki Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-MDA5 Dermatomyositis Induced by COVID-19 Following Recombinant　SARS-CoV-2 Vaccination: A Case Report 2025 ·The Tohoku Journal of Experimental Medicine ·(unknown), Shuzo Sato, (unknown), Kenji Saito, Shuhei Yoshida, (unknown), Jumpei Temmoku, (unknown), Tomoyuki Asano, Toshiyuki Yamamoto, Kiyoshi Migita	0
2	Unexpected adverse event caused by avacopan: a case of drug-induced hypersensitivity syndrome in microscopic polyangiitis 2025 ·Modern Rheumatology Case Reports ·(unknown), (unknown), (unknown), (unknown), Hiroki Irie, Naoki Konno, Yukiko Kanno, (unknown), (unknown), (unknown), Kazuhiro Tasaki, Tomoyuki Asano, Shuzo Sato, Masayuki Miyata	1
3	Organ damage accrual in patients with newly onset systemic lupus erythematosus with neuropsychiatric symptoms and its clinical features in daily clinical practice: a single-center study 2025 ·Immunological Medicine ·Kenji Saito, (unknown), Shuzo Sato, (unknown), (unknown), Shuhei Yoshida, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Tomoyuki Asano	0
4	Successful treatment of rheumatoid arthritis complicated by anti-Jo-1 antibody-positive myopathy with abatacept: A case report 2025 ·FUKUSHIMA JOURNAL OF MEDICAL SCIENCE ·Shuhei Yoshida, Jumpei Temmoku, Kenji Saito, Eiji Suzuki, Takashi Kanno, (unknown), Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita	0
5	Idiopathic Multicentric Castleman Disease Diagnosed after Lower Extremity Venous Thrombosis Mimicking Immunoglobulin G4-related Disease 2024 ·Internal Medicine ·(unknown), Haruki Matsumoto, Shuhei Yoshida, Kenji Saito, Tomoyuki Asano, (unknown), Takashi Kanno, (unknown)	1
6	New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review 2024 ·Internal Medicine ·(unknown), Jumpei Temmoku, Kenji Saito, Shuhei Yoshida, Haruki Matsumoto, (unknown), (unknown), Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita	2
7	Elderly-onset Familial Mediterranean Fever Carrying <i>MEFV</i> Exon 10 Variants in a Japanese Patient 2024 ·Internal Medicine ·(unknown), (unknown), (unknown), Kenji Saito, Shuhei Yoshida, Haruki Matsumoto, Tomoyuki Asano, Shuzo Sato, M. Yanagida, Shotaro Naito, Kiyoshi Migita	0
8	Adult-onset Still's Disease with Acute Kidney Injury Requiring Hemodialysis: A Case Report and Literature Review 2023 ·Internal Medicine ·Kenji Saito, Jumpei Temmoku, (unknown), Shuhei Yoshida, (unknown), Shuhei Watanabe, Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Hiroshi Watanabe, Kiyoshi Migita	2
9	Colchicine-resistant sacroiliitis in a Japanese patient with familial Mediterranean fever 2023 ·Modern Rheumatology Case Reports ·Haruki Matsumoto, (unknown), Kenji Saito, Shuhei Yoshida, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita	1
10	Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse 2023 ·Lupus Science & Medicine ·Shuzo Sato, (unknown), Naoki Matsuoka, (unknown), Kenji Saito, Shuhei Yoshida, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Tomoyuki Asano, Kiyoshi Migita	10
11	Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis 2023 ·Journal of Personalized Medicine ·Shuhei Yoshida, Eiji Suzuki, (unknown), Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Hiroshi Watanabe, Kiyoshi Migita	0
12	Safety of JAK and IL-6 inhibitors in patients with rheumatoid arthritis: a multicenter cohort study 2023 ·Frontiers in Immunology ·Shuhei Yoshida, Masayuki Miyata, Eiji Suzuki, Takashi Kanno, (unknown), Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita	10
13	Real-World Effectiveness of Belimumab in Patients with Active Lupus 2023 ·Journal of Clinical Medicine ·(unknown), Shuhei Yoshida, Eiji Suzuki, Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita	3
14	Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan 2022 ·Cancer Biotherapy and Radiopharmaceuticals ·Akira Matsumura, Tomoyuki Asano, Katsumi Hirose, Hiroshi Igaki, Shinji Kawabata, Hiroaki Kumada	29
15	An unusual case of familial Mediterranean fever complicated with protracted peritonitis 2021 ·Haruki Matsumoto, Yuya Fujita, Tomoyuki Asano, Shuzo Sato, Jumpei Temmoku, (unknown), Naoki Matsuoka, Hiroshi Watanabe, Eiji Suzuki, Kiyoshi Migita	1
16	Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still’s disease 2021 ·PLoS ONE ·Yuya Fujita, Toru Yago, Tomoyuki Asano, Haruki Matsumoto, Naoki Matsuoka, Jumpei Temmoku, Shuzo Sato, (unknown), Eiji Suzuki, Hiroshi Watanabe, Atsushi Kawakami, Kiyoshi Migita	10
17	Adult-Onset Still’s Disease Complicated by Immunoglobulin A Vasculitis and anti-CCP Antibody-Positive Arthritis 2021 ·The Tohoku Journal of Experimental Medicine ·Yuya Fujita, Shuzo Sato, Haruki Matsumoto, Jumpei Temmoku, (unknown), Naoki Matsuoka, Tomoyuki Asano, (unknown), Shuhei Yoshida, Mikio Ohtsuka, Hiroshi Watanabe, Kiyoshi Migita	0
18	T cell immunoglobulin and mucin domain-3 is associated with disease activity and progressive joint damage in rheumatoid arthritis patients 2020 ·Medicine ·Haruki Matsumoto, Yuya Fujita, Tomoyuki Asano, Naoki Matsuoka, Jumpei Temmoku, Shuzo Sato, (unknown), Hiroshi Watanabe, Kiyoshi Migita	10
19	The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis 2018 ·Medicine ·Tomoyuki Asano, (unknown), Aya Watanabe, (unknown), (unknown), (unknown), Shuzo Sato, Hiroko Kobayashi, Hiroshi Watanabe, (unknown), Takashi Kanno, (unknown), Shiro Ishii, Kiyoshi Migita	4
20	Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils 2018 ·Arthritis Research & Therapy ·Makiko Yashiro Furuya, Tomoyuki Asano, (unknown), Shuzo Sato, Hiroko Kobayashi, Hiroshi Watanabe, Eiji Suzuki, Hideko Kozuru, Hiroshi Yatsuhashi, Tomohiro Koga, Hiromasa Ohira, Hideharu Sekine, Atsushi Kawakami, Kiyoshi Migita	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact